Literature DB >> 2926150

A new compact and cell dense continuous culture system.

Y Nakamura1, K Watanabe, T Noto, T Tajima, M Yamamura.   

Abstract

A new compact and cell dense continuous culture system was developed. The system consisted of a culture bag, which had two compartments separated by a semipermeable membrane, and an external rotator. Cells were cultured in the inner compartment with medium containing serum or the necessary growth factors. The outer compartment was filled with medium without serum or growth factors. The concentration of cells in culture was normally in the order of 10(7). Due to the large number of cells, sufficient carbon dioxide was produced so that use of a CO2 incubator was unnecessary. The medium in the outer part was frequently changed, but no medium changes were necessary in the inner bag. Using this system, a concentrated yield of antibody as well as a large number of cells could be obtained.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2926150     DOI: 10.1016/0022-1759(89)90049-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Determination of division rates of rCHO cells in high density and immobilized fermentation systems by flow cytometry.

Authors:  N Borth; M Reiter; G Blüml; C Schmatz; T Gaida; H Katinger
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Increase of hybridoma productivity using an original dialysis culture system.

Authors:  B Mathiot; A Perani; D Dumas; M Maugras; J Didelon; J F Stoltz
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

3.  A new high-yield continuous cell-culture system for lymphokine-activated killer cells.

Authors:  T Noto; Y Tokuda; Y Nakamura; A Suzuki; K Watanabe; M Yamamura; T Tajima; T Mitomi; K Nishijima
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.

Authors:  Y Nakamura; Y Tokuda; M Iwasawa; H Tsukamoto; M Kidokoro; N Kobayashi; S Kato; T Mitomi; S Habu; T Nishimura
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.